-
Mashup Score: 2DVT ultrasounds in emergency departments could reduce overcrowding - 7 month(s) ago
Patient time in emergency departments could be halved if doctors working there were trained to carry out ultrasound on patients with suspected deep vein thrombosis (DVT), a major conference has heard. Dr Ossi Hannula, an emergency medicine specialist at the Wellbeing Services County of Central Finland, told delegates at the European Emergency Medicine Congress it could mean the difference of more…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1New treatment option for adult multiple myeloma - 7 month(s) ago
The range of drug treatments for multiple myeloma is set to be extended, NHS advisers have said. New draft guidance on a drug for multiple myeloma has been released by the National Institute for Health and Care Excellence (NICE). The drugs daratumumab plus lenalidomide and dexamethasone are recommended for previously untreated multiple myeloma in adults, if an autologous stem cell transplant…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The range of drug treatments for multiple myeloma is set to be extended, NHS advisers have said. Read the latest #BSHNews story here: https://t.co/3Gpei1kBrE https://t.co/vnL1KEzenT
-
-
Mashup Score: 1BSH Global Speakers - 7 month(s) ago
In 2016, representatives from the British Society for Haematology (BSH) and haematologists from low- and middle-income countries (LMIC) met to decide the priorities of the Global Haematology Special Interest Group (SIG). One priority was identifying BSH speakers to visit LMIC haematology meetings to establish links and collaborative projects. We built on the success of the 2017 pilot project to…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We are accepting applications for the BSH Global Speakers Scheme 2023. The aim of this scheme is to form collaborative partnerships between BSH and haematology societies in low and middle-income countries to share knowledge and expertise. https://t.co/GJwMFCz7yR https://t.co/wxxpRp0JOt
-
-
Mashup Score: 1September 2023 Message from BSH President - Dr Josh Wright - 7 month(s) ago
I start this month’s message with some sad news: Katy Amberley, who has been with the BSH for 16 years and Chief Executive Officer since 2017, will leave us at the end of 2023. Katy has steered the BSH through difficult times and has been instrumental in turning around the Annual Scientific Meeting and the Society more widely. Her loyalty, integrity and consistent attention to detail have been…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The BSH Board of Trustees met up last week to discuss the new three-year strategy Read more about this in Dr Josh Wright's September president message: https://t.co/7e7RYUJw4U https://t.co/AB7LzhJWRi
-
-
Mashup Score: 2BSH statement on Physician Associates and related roles - 7 month(s) ago
The NHS workforce is widely acknowledged to be facing a severe shortage of staff numbers. Indeed, the government has recently announced its NHS Workforce Plan to try to tackle this problem. One of the key clinical disciplines facing a really acute shortage – a discipline on whom so many other clinical colleagues depend – is haematology. The BSH is therefore greatly encouraged to see the rising…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The NHS workforce is widely acknowledged to be facing a severe shortage of staff numbers. Read the BSH statement on Physician Associates and related roles on our website here: https://t.co/EUpSGu1cGN #BSHNews #BSH https://t.co/iofPFdzQXe
-
-
Mashup Score: 1Thromboembolism risk from multiple factors assessed - 8 month(s) ago
The Factor V Leiden gene variation can combine with other factors to place some women at risk of blood clots when using oestrogen-based drugs, according to a new study. It is already known that multimorbidity – the co-occurrence of two or more chronic conditions – oestrogen use, and the Factor V Leiden variation are independent risk factors for venous thromboembolism (VTE). However, little is…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The Factor V Leiden gene variation can combine with other factors to place some women at risk of blood clots when using oestrogen-based drugs, according to a new study. Read the latest #BSHNews story here: https://t.co/6JwEucSSDr https://t.co/yWCfafbMmM
-
-
Mashup Score: 1Discovery brings new hope for improved myeloma treatments - 8 month(s) ago
Treatment for an aggressive form of myeloma could improve after scientists uncovered new insights into how a class of enzymes and its epigenetic target can make the blood cancer aggressive and resistant to treatment. Compared with other types of myeloma, patients with t(4;14) myeloma have a poorer prognosis with shorter overall survival. The histone methyltransferase NSD2 is over-produced in…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Treatment for an aggressive form of myeloma could improve after scientists uncovered new insights into how a class of enzymes and its epigenetic target can make the blood cancer aggressive and resistant to treatment. Read the latest #BSHNews story here: https://t.co/498VWN76vH https://t.co/7FdrsVzf8t
-
-
Mashup Score: 0Preparations for blood group genotyping for people with sickle cell, thalassemia and rare anaemia - 8 month(s) ago
Please see below a letter regarding the preparation for the national Sickle Cell, Thalassaemia & Other Rare Inherited Anaemias Blood Group Genotyping Programme from the NHSBT. Read the full letter here.
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A message from @NHSBT Preparations for blood group genotyping for people with sickle cell, thalassemia and rare anaemia Read the latest #BSHNews story here: https://t.co/OObvoKvzg8 https://t.co/Ur4y3dtBPp
-
-
Mashup Score: 4Mechanisms of multiple myeloma therapy resistance identified - 8 month(s) ago
Mechanisms by which some multiple myelomas become resistant to certain T-cell therapies have been uncovered by an international team of scientists. Multiple myeloma can be treated with CAR-T cells and bispecific T cell engagers (TCE), directed against one or both of two targets: BCMA, and GPRC5D. However, mutations in the myeloma cells can render these immunotherapies ineffective – allowing…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Mechanisms by which some multiple myelomas become resistant to certain T-cell therapies have been uncovered by an international team of scientists. Read the latest #BSHNews story here: https://t.co/4fjw7wTsIR https://t.co/GynNqITngj
-
-
Mashup Score: 1Blood clots clue to ‘long-COVID’ cognitive issues - 8 month(s) ago
The development of blood clots during COVID-19 infection could be behind continued cognitive problems of some individuals, a new paper has suggested. A team led by Dr Max Taquet and Prof Paul Harrison from the University of Oxford analysed blood tests from 1,837 people who had been hospitalised with COVID-19. They found two potential biomarkers measured at admission associated with subsequent…
Source: BSHCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The development of blood clots during COVID-19 infection could be behind continued cognitive problems of some individuals, a new paper has suggested. Read the latest #BSHNews story here: https://t.co/ZgfrXxKzlU https://t.co/xeJD89ZlUO
-
Patient time in emergency departments could be halved if doctors working there were trained to carry out ultrasound on patients with suspected deep vein thrombosis (DVT), a major conference has heard. Read the latest #BSHNews story here: https://t.co/uKPancRjlm https://t.co/gMPpYBB1Ii